120 related articles for article (PubMed ID: 31805655)
21. Pharmacokinetics and pharmacodynamics of mycophenolic acid in stable renal transplant recipients treated with low doses of mycophenolate mofetil.
Brunet M; Martorell J; Oppenheimer F; Vilardell J; Millán O; Carrillo M; Rojo I; Corbella J
Transpl Int; 2000; 13 Suppl 1():S301-5. PubMed ID: 11112019
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function.
Shaw LM; Mick R; Nowak I; Korecka M; Brayman KL
J Clin Pharmacol; 1998 Mar; 38(3):268-75. PubMed ID: 9549665
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic Analysis of Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium in Calcineurin Inhibitor-Free Renal Transplant Recipients.
Graff J; Scheuermann EH; Brandhorst G; Oellerich M; Gossmann J
Ther Drug Monit; 2016 Jun; 38(3):388-92. PubMed ID: 26829599
[TBL] [Abstract][Full Text] [Related]
24. A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.
van Gelder T; Hilbrands LB; Vanrenterghem Y; Weimar W; de Fijter JW; Squifflet JP; Hené RJ; Verpooten GA; Navarro MT; Hale MD; Nicholls AJ
Transplantation; 1999 Jul; 68(2):261-6. PubMed ID: 10440399
[TBL] [Abstract][Full Text] [Related]
25. Limited sampling strategy for simultaneous estimation of the area under the concentration-time curve of tacrolimus and mycophenolic acid in adult renal transplant recipients.
Miura M; Satoh S; Niioka T; Kagaya H; Saito M; Hayakari M; Habuchi T; Suzuki T
Ther Drug Monit; 2008 Feb; 30(1):52-9. PubMed ID: 18223463
[TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up of pediatric transplant recipients: mycophenolic acid trough levels are not a good indicator for long-term graft function.
Pape L; Ehrich JH; Offner G
Clin Transplant; 2004 Oct; 18(5):576-9. PubMed ID: 15344963
[TBL] [Abstract][Full Text] [Related]
27. Limited sampling strategy for the estimation of mycophenolic acid area under the curve in Tunisian renal transplant patients.
Gaies E; Ben Sassi M; El Jebari H; Jebabli N; Charfi R; Chokri I; Salouage I; Klouz A; Trabelsi S
Nephrol Ther; 2017 Nov; 13(6):460-462. PubMed ID: 28958670
[TBL] [Abstract][Full Text] [Related]
28. Limited Sampling Strategy for the Estimation of Mycophenolic Acid and its Acyl Glucuronide Metabolite Area under the Concentration-Time Curve in Japanese Lung Transplant Recipients.
Tanaka M; Kikuchi M; Takasaki S; Hirasawa T; Sigeta K; Noda A; Akiba M; Matsuda Y; Oishi H; Sado T; Noda M; Okada Y; Mano N; Yamaguchi H
J Pharm Pharm Sci; 2019; 22(1):407-417. PubMed ID: 31430249
[TBL] [Abstract][Full Text] [Related]
29. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M
Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
[TBL] [Abstract][Full Text] [Related]
30. Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation.
Mino Y; Naito T; Matsushita T; Otsuka A; Ushiyama T; Ozono S; Hishida A; Kagawa Y; Kawakami J
Ther Drug Monit; 2008 Dec; 30(6):656-61. PubMed ID: 18978521
[TBL] [Abstract][Full Text] [Related]
31. Short-term pharmacokinetic study of mycophenolate mofetil in neonatal swine.
Pan H; Gazarian A; Fourier A; Gagnieu MC; Leveneur O; Sobh M; Michallet MC; Buff S; Roger T; Dubernard JM; Michallet M
Transplant Proc; 2014 Dec; 46(10):3620-8. PubMed ID: 25498100
[TBL] [Abstract][Full Text] [Related]
32. A prospective analysis of the effects of enteric-coated mycophenolate sodium and mycophenolate mofetil co-medicated with a proton pump inhibitor in kidney transplant recipients at a single institute in China.
Xu L; Cai M; Shi BY; Li ZL; Li X; Jin HL
Transplant Proc; 2014 Jun; 46(5):1362-5. PubMed ID: 24935300
[TBL] [Abstract][Full Text] [Related]
33. Limits to intensified mycophenolate mofetil dosing in kidney transplantation.
Kiberd BA; Lawen J; Daley C
Ther Drug Monit; 2012 Dec; 34(6):736-8. PubMed ID: 23007746
[TBL] [Abstract][Full Text] [Related]
34. Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokinetics.
Pescovitz MD; Conti D; Dunn J; Gonwa T; Halloran P; Sollinger H; Tomlanovich S; Weinstein S; Inokuchi S; Kiberd B; Kittur D; Merion RM; Norman D; Shoker A; Wilburn R; Nicholls AJ; Arterburn S; Dumont E
Clin Transplant; 2000 Jun; 14(3):179-88. PubMed ID: 10831074
[TBL] [Abstract][Full Text] [Related]
35. Circadian pharmacokinetics of mycophenolic Acid and implication of genetic polymorphisms for early clinical events in renal transplant recipients.
Satoh S; Tada H; Murakami M; Tsuchiya N; Li Z; Numakura K; Saito M; Inoue T; Miura M; Hayase Y; Suzuki T; Habuchi T
Transplantation; 2006 Aug; 82(4):486-93. PubMed ID: 16926592
[TBL] [Abstract][Full Text] [Related]
36. Age-related variability of mycophenolate mofetil exposure in stable pediatric liver transplant recipients and influences of donor characteristics.
Parant F; Rivet C; Boulieu R; Gagnieu MC; Dumortier J; Boillot O; Lachaux A
Ther Drug Monit; 2009 Dec; 31(6):727-33. PubMed ID: 19881404
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid.
van Gelder T; Klupp J; Barten MJ; Christians U; Morris RE
Ther Drug Monit; 2001 Apr; 23(2):119-28. PubMed ID: 11294511
[TBL] [Abstract][Full Text] [Related]
38. No relevant pharmacokinetic interaction between pantoprazole and mycophenolate in renal transplant patients: a randomized crossover study.
Rissling O; Glander P; Hambach P; Mai M; Brakemeier S; Klonower D; Halleck F; Singer E; Schrezenmeier EV; Dürr M; Neumayer HH; Budde K
Br J Clin Pharmacol; 2015 Nov; 80(5):1086-96. PubMed ID: 25913040
[TBL] [Abstract][Full Text] [Related]
39. Dose-normalization for exposure to mycophenolic acid and the early clinical outcome in patients taking tacrolimus after heart transplantation.
Roan JN; Chou CH; Hsu CH; Wu SY; Huang YC; Yang YJ; Luo CY
Ann Transplant; 2013 Feb; 18():43-52. PubMed ID: 23792500
[TBL] [Abstract][Full Text] [Related]
40. Atypical pharmacokinetics and metabolism of mycophenolic acid in a young kidney transplant recipient with impaired renal function.
Wigger M; Armstrong VW; Shipkova M; Wacke R; Nizze H; Streit F; von Ahsen N; Muscheites J; Glasenapp S; Stolpe HJ; Oellerich M
Ther Drug Monit; 2002 Jun; 24(3):438-43. PubMed ID: 12021639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]